• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

April 2, 2004

View Archived Issues

Beta adrenergic receptor targeted for treatment of male sexual dysfunction

Read More

Promising results of an HCV E1-based vaccine in hepatitis C patients

Read More

NPS Pharmaceuticals announces phase III clinical results for Preos in osteoporosis

Read More

Potent syncretic antimitotic agent by CombinatoRx

Read More

Novel bifunctional small molecule inhibitor to treat neurodegenerative diseases

Read More

Potassium channel openers for migraine and neuropathic pain from BMS

Read More

BMS-554216, a prodrug of BMS-204352, shows improved pharmacokinetics

Read More

MIV-150/Carraguard microbicide demonstrates encouraging preclinical results

Read More

Eisai to acquire Elan's Zonegran rights

Read More

Schering-Plough signs letter of intent for rights to garenoxacin

Read More

Axcan receives European marketing approval for Photobarr PDT

Read More

GenVec, PATH's MVI and NMRC expand malaria vaccine efforts

Read More

Guilford regains NAALADase inhibitor rights from Pfizer

Read More

Results from European phase III trial of Polyphenon E Ointment

Read More

GlaxoSmithKline and Theravance to form strategic alliance

Read More

Lupin to promote Zymar to U.S. pediatricians

Read More

Enrollment completed in second pivotal trial for Neurodex

Read More

Final statistical plan agreed for two pivotal Targretin trials

Read More

Intravenous Remodulin sNDA accepted for review

Read More

New phase I trial studies safety and immunogenicity of Vical's CMV vaccine

Read More

Kissei patent covers SGLT1 inhibitors for diabetes, obesity, etc.

Read More

Novel PARP inhibitors emerge from research at Kyorin

Read More

Cephalosporin derivatives with activity against MRSA disclosed

Read More

Ono discovers a novel series of PPAR inhibitors

Read More

Antiviral pyrazine derivatives designed by Toyama

Read More

Pfizer patent claims combinations of alpha-2-delta ligand/PDEV inhibitor for treatment of pain

Read More

Radioimmunotherapy with 131I-cG250 assessed in renal cell carcinoma

Read More

WX-G250 plus IFNalpha-2a reported safe and effective in renal cell carcinoma

Read More

OM-89 reduces the incidence of urinary tract infections in women

Read More

Ono claims use of ornoprostil to reduce diclofenac side effects, improve activity

Read More

Alfuzosin reduces need for surgery in acute urinary retention

Read More

CHIR-124, a novel small-molecule quinolone-based inhibitor of the CHK1 checkpoint

Read More

Ki-23057, a potent, metabolically stable inhibitor of FGFR2 characterized by Kirin

Read More

Pfizer presents data on PD-0325901, a more potent and pharmaceutically improved analogue of CI-1040

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe